The role of modern drugs of targeted action in the management of patients with tonsillar pathology
https://doi.org/10.21518/2079-701X-2018-8-36-40
Abstract
The article highlights the problem of acute tonsillopharyngitis and chronic tonsillitis – epidemiology, clinical picture, diagnosis, principles of treatment, including the possibility of using drugs with target action. Data on the practical effectiveness and safety of Tonsilotren® are presented on the basis of data from Russian and foreign literature.
About the Authors
V. M. Svistushkin
I.M.Sechenov First Moscow State Medical University of the Ministry of Health of Russia (Sechenov university)
Russian Federation
MD, Prof.
Russian Federation
MD, Prof.
G. N. Nikiforova
I.M.Sechenov First Moscow State Medical University of the Ministry of Health of Russia (Sechenov university)
Russian Federation
MD, Prof.
Russian Federation
MD, Prof.
L. A. Toporkova
I.M.Sechenov First Moscow State Medical University of the Ministry of Health of Russia (Sechenov university)
Russian Federation
Russian Federation
References
1. Palchun VT. Otorhinolaryngology: national leadership. Moscow: GEOTAR-Media. 2016. 1024 p.
2. Karneeva OV, Daikhes NA, Polyakov DP. Protocols for diagnosis and treatment of acute tonsillopharyngitis. RMJ, 2015, 6: 307-311.
3. Acute tonsillopharyngitis. KR306. Clinical guidelines. National Medical Association of Otorhinolaryngologists. 2016 24 p.
4. Sidorenko SV, Guchev IA. Tonsillopharyngitis: issues of diagnostic and antibiotic therapy. Consilium medicum. Infektsii i Antimikrobnaya Terapiya, 2004, 06 (4): 120-126.
5. Bochner RE, Gangar M, Belamarich PF. A clinical approach to tonsillitis, tonsillar hypertrophy, and peritonsillar and retropharyngeal abscesses. Pediatrics in Review, 2017, 38(2): 81-92.
6. ESCMID Sore Throat Guideline Group. Pelucchi C, Grigoryan L, Galeone C, Esposito S, Huovinen P, Little P, Verheij T. Guideline for the management of acute sore throat. Clinical Microbiology and Infection, 2012, 18(1): 1-28.
7. Bisno AL. Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Infectious Diseases in Clinical Practice, 2002, 35(2): 113-25.
8. Maltseva GS. The role of group A beta-hemolytic streptococcus in tonsillar pathology. Rossiyskaya Otorinolaringologiya, 2007, 3 (28): 131-139.
9. Palchun VT, Gurov AV. Focal infection and septic conditions in otorhinolaryngological practice. Vestnik Otorinolaringologii, 2009, 6: 63-68.
10. Gurov AV. A clinical pharmacologist and microbiologist’s view on the diagnosis and rational therapy of acute and chronic tonsillitis. Consilium medicum, 2012, extra release: 3-4.
11. Anne CL, Kemper KJ. Homeopathy and Naturopathy Practice Characteristics and Pediatric Care. Arch Pediatr Adolesc Med, 2000, 154(1): 75-80.
12. Jacobs J, Moskowitz R. Homeopathy. Micozzi Med. Fundamentals of Complemetary and Alternative Medicine. New York. Churchill Livingstone Inc. 1996: 67-78.
13. Linde K, Clausius N, Ramirez G et al. Are the clinical effects of homeopathy placebo effects? A meta-analysis of placebo-controlled trials. Lancet, 1997, 350: 834-843.
14. Shang A, Huwiler-Müntener K, Nartey L et al. Are the effects of homoeopathy placebo effects? Comparative study of placebo-controlled trials of homoeopathy and allopathy. Lancet, 2005, 366: 726-732.
15. Patient Information Leaflet for Tonsilotren. П N012166/01-150513
16. Friese KH, Timen GE, Zabalotnyi DI. Homeopathy in children with nonstreptococcal tonsillitis. Study proves efficacy and tolerability of a homeopathic combination medicine. Der Kassenarzt, 2006, 6: 402.
17. Palm J, Kishchuk V, Keller T et all. Tonsilotren in chronic tonsillitis: Results of a randomised, international, controlled clinical trial. European Journal of Integrative Medicine, 2016, 8S: 37.
18. Buskin S, Pilar M, Huckstadt R, Salatino S. Use of natural and homeopathic remedies in children ailments. CMI, 2016, 10(2): 33-48.
19. Melnikov OF, Timchenko SV, Pharaoh IV, Bredun AYu. Investigation of the anti-inflammatory properties of tonsilotrene in the experiment. Zhurnal Vushnikh, Nosovikh i Gorlovikh Khvorob, 2008, 6: 37
20. Abdrakhmanova GM. Experience of comprehensive preventive management of tonsillitis at the out-patient-polyclinic stage. Klinicheskaya Meditsina Kazakhstana, 2011, 3-4 (22-23): 369-370.
21. Podporina LA, Peschaniy VA. New prospects for management of children with hypertrophy of palatine tonsils and manifestations of vegetative dystonia syndrome in outpatient settings. Materials of the Scientific Practical Conference “Topical Issues of Paediatrics, Neonatology and Paediatric Surgery”. Krasnodar. 2016: 168-171.
Review
For citations:
Svistushkin VM, Nikiforova GN, Toporkova LA. The role of modern drugs of targeted action in the management of patients with tonsillar pathology. Meditsinskiy sovet = Medical Council. 2018;(8):36-40. (In Russ.) https://doi.org/10.21518/2079-701X-2018-8-36-40
Views:
701
Email this article 